
Poland and Slovenia Added to EU–US Mutual Recognition Agreement
The two countries have been included in the mutual recognition agreement between the EU and US for GMP inspections.
On Feb. 11, 2019, the European Medicines Agency (EMA)
The agreement allows the EU and the US to focus its resources on other parts of the world and prioritize on higher-risk sites. It also reduces administrative burdens and costs that would be incurred by duplicate inspections.
With the addition of Poland and Slovenia, the total number of EU countries involved in the agreement is now at 22 Member States. It is anticipated that all EU Member States will be involved by July 15, 2019.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.